Tenderwize
Back to tender search

Discount agreement for Calcipotriol/Betamethasone cream

AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen·Dresden, Germany·Deadline May 31, 2028 · 601 days left·Open·Supplies·Framework
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Calcipotriol/Betamethason - Creme (amtlicher ATC-Code: D05AX22)

30/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

30 / 100

Complexity

20 / 100

Risk factors

No guaranteed purchase quantities; actual demand is uncertain and dependent on physician prescribing and pharmacy prefe...

The authority may terminate the Open-House process early if exclusive discount agreements are concluded, typically with...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
May 31, 2028

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Supply of Calcipotriol/Betamethasone cream (ATC D05AX22) as a pharmaceutical product
  • Conclusion of non-exclusive discount agreements under § 130a Abs. 8 SGB V
Show full summary

This is an Open-House model (non-competitive) for non-exclusive drug discount agreements under § 130a Abs. 8 SGB V for the active substance Calcipotriol/Betamethasone (ATC D05AX22) in cream form. The contracting authority is AOK PLUS for Saxony and Thuringia, Germany. The agreement runs until 31 May 2028, with no guarantee of minimum purchase quantities. The tender is published voluntarily on TED for transparency; it is not a public procurement subject to EU directives. Important: the discount terms are confidential and only accessible after requesting access to the DTVP project room.

Risks

No guaranteed purchase quantities; actual demand is uncertain and dependent on physician prescribing and pharmacy prefe...

The authority may terminate the Open-House process early if exclusive discount agreements are concluded, typically with...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG with respect to the offered medicinal product
  • Must have registered seat in Germany, EU, or EEA (§ 9 Abs. 2 AMG)

Eligibility

  • Submit self-declaration on exclusion grounds (§§ 123, 124 GWB)

Requirements may be incomplete.

Award Criteria

Lot 1

No explicit award criteria provided; the agreement is based on acceptance of the discount terms, not on competitive scoring.

Buyer

Location

Dresden, DEU

Buyer profile

Open profile

Identifier

DE256878834

Activity

Health

Lots (1)

LOT-0001

Discount agreement for Calcipotriol/Betamethasone cream

Non-exclusive discount agreement for the supply of Calcipotriol/Betamethasone cream. Open to all qualified pharmaceutical entrepreneurs who accept the terms. No individual negotiations; no exclusivity. No guaranteed volumes.

SuppliesFrameworkEU fundedElectronic submission

Location

Dresden, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Award Criteria

No explicit award criteria provided; the agreement is based on acceptance of the discount terms, not on competitive scoring.

Deadline

Deadline May 31, 2028

Procurement Details

Publication date
25 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
207477-2026

Documents (1)

Procurement document 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

Dec 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30